Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

80° Partly Cloudy
- Plymouth, IN (46563)
  Today
  
  Thunderstorms during the evening will give way to cloudy skies after midnight. Low 63F. Winds NNE at 5 to 10 mph. Chance of rain 80%..
  
  Tonight
  
  Thunderstorms during the evening will give way to cloudy skies after midnight. Low 63F. Winds NNE at 5 to 10 mph. Chance of rain 80%.
  
  Updated: September 17, 2026 @ 6:22 pm
- Full Forecast

Site search

News
- Local News
- The Leader
Sports
Obituaries
Classifieds
Archives
Best of 2026
Pilot News E-Edition
Culver Citizen

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by MiNK Therapeutics

< Previous 1 2 3 Next >

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024

March 06, 2024

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab

February 14, 2024

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications

February 06, 2024

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene

January 30, 2024

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

December 20, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Reports Third Quarter 2023 Results

November 09, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023

November 03, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update

October 30, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023

September 27, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Participate in September Investor Conferences

August 24, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Reports Second Quarter 2023 Results

August 10, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update

July 28, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

June 05, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference

May 22, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK's Novel FAP-CAR-iNKT Presented at ASGCT

May 18, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results

May 11, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results

April 27, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting

April 18, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

March 21, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting

March 15, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results

March 07, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference

February 16, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference

January 11, 2023

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference

November 17, 2022

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline

November 10, 2022

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results

November 03, 2022

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update

October 20, 2022

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Host R&D Event November 10, 2022

October 05, 2022

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

October 05, 2022

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update

July 27, 2022

From MiNK Therapeutics

Via GlobeNewswire

Tickers INKT

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Search
Weather

www.thepilotnews.com
218 N. Michigan
Plymouth, IN 46563
Phone: 574-936-3101
Email: webmaster@thepilotnews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Plymouth, IN (46563)

Today

Tonight

Articles published by MiNK Therapeutics

Sections

Services